ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
Goldman Sachs tips Ramsay shares as a sell
Share Market News
Goldman Sachs tips ResMed share price as a buy
Share Market News
Goldman Sachs tips CSL share price to hit $300
52-Week Highs
Why ResMed and these ASX shares just stormed to 52-week highs
52-Week Highs
Why the ResMed share price just hit a new 52-week high
Growth Shares
Where to invest $1,000 in ASX shares this month
Record Highs
Qantas share price tipped to test new highs next month
Growth Shares
Where to invest $10,000 into ASX 200 shares in 2020
Share Market News
2 ASX healthcare shares just hit all-time highs. Should you invest?
How to invest
This is how to turn $20,000 into $150,000 with ASX shares
Share Market News
5 things to watch on the ASX 200 on Wednesday
Share Market News
Top brokers name 3 ASX shares to buy next week
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
